These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 8860358)

  • 1. Diagnosis of Epstein-Barr virus-related diseases.
    Linde A
    Scand J Infect Dis Suppl; 1996; 100():83-8. PubMed ID: 8860358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and immunological considerations in Epstein-Barr virus-associated diseases.
    Andersson J
    Scand J Infect Dis Suppl; 1996; 100():72-82. PubMed ID: 8860357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
    J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The diagnostic value of Epstein-Barr virus diagnosis].
    Bauer G
    Internist (Berl); 1992 Sep; 33(9):586-92. PubMed ID: 1328107
    [No Abstract]   [Full Text] [Related]  

  • 5. The Epstein-Barr virus (EBV) in human pathology. II. Serologic profiles of EBV infections.
    Didier J; Dalens M; Chabanon G; Icart J; Enjalbert L
    Biomedicine; 1978; 28(1):54-62. PubMed ID: 208675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of serological criteria for the diagnosis of infectious mononucleosis].
    de Ory F; Echevarría JM
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):485-8. PubMed ID: 2562304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus and cytomegalovirus antibodies in infectious mononucleosis.
    Gergely L; Czeglédy J; Szalka A; Váczi L; Binder L
    Acta Microbiol Acad Sci Hung; 1977; 24(1):13-9. PubMed ID: 201153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children.
    Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L
    Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
    Kaschka WP; Hilgers R; Skvaril F
    Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EBV diseases].
    Weber J
    Monatsschr Kinderheilkd; 1986 Feb; 134(2):60-6. PubMed ID: 3010085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
    Chow KC; Ma J; Lin LS; Chi KH; Yen SH; Liu SM; Liu WT; Chen WK; Chang TH; Chen KY
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):363-8. PubMed ID: 9149897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and human papillomavirus infections and oropharyngeal squamous cell carcinomas.
    Szkaradkiewicz A; Kruk-Zagajewska A; Wal M; Jopek A; Wierzbicka M; Kuch A
    Clin Exp Med; 2002 Nov; 2(3):137-41. PubMed ID: 12447611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.